Press release
Semi Solid Dosage CDMO Market Size is expected to have the highest CAGR from 2022 to 2033 | Emergen Research
Download Free Exclusive Sample PDF@https://www.emergenresearch.com/request-sample/3397
Key Drivers of Market Growth
Growing Demand for Dermatological Products
The rising prevalence of skin conditions such as eczema, psoriasis, acne, and rosacea is a major growth factor for the market. These conditions, exacerbated by changing lifestyles, pollution, and stress, require effective treatments in the form of creams, gels, and ointments. These formulations are preferred for their localized effects and reduced risk of side effects, leading to increased demand for innovative semi-solid therapies.
The growing global focus on skincare, driven by increased consumer awareness of skin health, has also expanded the demand for both therapeutic and cosmetic products. From anti-aging creams to prescription-based dermatological treatments, the market is experiencing a surge in demand across various segments.
Rise in Outsourcing Trends
Pharmaceutical and biotechnology companies are increasingly outsourcing their development and manufacturing processes to CDMOs. This trend allows companies to focus on core activities like research and marketing while leaving the complexities of semi-solid dosage production to specialized CDMOs.
CDMOs bring technical expertise, advanced facilities, and regulatory knowledge to the table, ensuring high-quality and compliant products. Their ability to handle complex formulations and accelerate time-to-market has made them indispensable partners for companies looking to meet growing consumer demands.
Challenges Facing the Market
High Competition Among CDMOs
The semi-solid dosage CDMO market is highly competitive, with numerous players vying for contracts. This competition has led to pricing pressures, particularly impacting smaller CDMOs with limited resources.
Larger CDMOs, equipped with advanced technologies and robust infrastructures, have a competitive edge in handling high-volume and complex projects. In contrast, smaller players often struggle to invest in cutting-edge equipment and expertise, limiting their ability to compete for high-value contracts.
Interested in knowing more relevant information? Click here:https://www.emergenresearch.com/industry-report/semi-solid-dosage-cdmo-market
Segment Insights
End-Use Dynamics
Pharmaceutical companies increasingly rely on CDMOs to handle the complexities of semi-solid dosage forms, including creams, gels, and ointments. These formulations require precise handling to ensure consistency, stability, and efficacy.
By outsourcing to CDMOs, pharmaceutical firms can focus on drug discovery and market expansion while benefiting from the CDMOs' advanced manufacturing capabilities and regulatory expertise. This strategy not only reduces operational risks but also accelerates the time-to-market for new products.
Semi Solid Dosage CDMO Market Top Companies and Competitive Landscape
The semi-solid dosage CDMO industry is a niche part of the pharmaceutical outsourcing market involved in the manufacturing of semi-solid dosage forms such as creams, ointments, gels, and pastes. Such products find wide applications in dermatology, transdermal delivery systems, and topical therapeutic applications.
Various factors are driving the growth of the semi-solid dosage CDMO sector, such as the increasing demand for topical drugs, growing preference for non-invasive drug delivery methods, and increasing need for contract manufacturing services in the pharmaceutical industry.
The Key players operating in the Semi Solid Dosage CDMO Market includes The Lubrizol Corporation, Cambrex Corporation, Contract Pharmaceuticals Limited., Bora Pharmaceutical, Ascendia Pharmaceuticals, Pierre Fabre group, Piramal Pharma Solutions, DPT Laboratories, LTD, LGM Pharma, Pace Analytical Life Sciences, LLC, and others.
In February 2024, the contract development and manufacturing organization, Recipharm signed an exclusive license and collaboration agreement with Medspray and Resyca. The collaboration was focused on the development of soft mist nasal delivery devices for both single and combination pharmaceutical products.
Some of the key companies in the global Semi Solid Dosage CDMO Market include:
The Lubrizol Corporation
Cambrex Corporation
Contract Pharmaceuticals Limited.
Bora Pharmaceutical
Ascendia Pharmaceuticals
Pierre Fabre group
Piramal Pharma Solutions
DPT Laboratories, LTD
LGM Pharma
Pace Analytical Life Sciences, LLC
Semi Solid Dosage CDMO Market Latest Industry Updates
In September 2024, Blue Wolf Capital Partners LLC announced the acquisition of the European pharmaceutical manufacturing facilities of Recipharm. These facilities are primarily involved in the manufacturing of semi-solid, oral solid, and liquid dosage form pharmaceutical products.
In July 2024, MedPharm announced a merger with Tergus Pharma to form a single Contract Development and Manufacturing Organization specializing in topical and transepithelial products. The new company will carry the brand name MedPharm and include a range of services comprising clinical trial manufacturing and full-scale commercial production.
Make Payment [Buy your Exclusive copy] @https://www.emergenresearch.com/select-license/3397
The main report offers detailed historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the segments from 2020 to 2033:
Semi Solid Dosage CDMO Market Segmentation Analysis
Route of Administration Outlook (Revenue, USD Billion; 2020-2033)
Topical
Transdermal
Others
Product Outlook (Revenue, USD Billion; 2020-2033)
Ointments
Creams and Lotions
Pastes
Gels
Others
Service Outlook (Revenue, USD Billion; 2020-2033)
Contract Development
Contract Manufacturing
End-Use Outlook (Revenue, USD Billion; 2020-2033)
Pharmaceutical Companies
Biopharmaceutical Companies
Others
Regional Outlook (Revenue, USD Billion; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Request Customization in The Report @ https://www.emergenresearch.com/request-for-customization/3397
Look Over transcripts provided by Emergen Research
Semi Solid Dosage CDMO Market Size @https://www.emergenresearch.com/industry-report/semi-solid-dosage-cdmo-market/market-size
Semi Solid Dosage CDMO Market Share @https://www.emergenresearch.com/industry-report/semi-solid-dosage-cdmo-market/market-share
Semi Solid Dosage CDMO Market Trends @https://www.emergenresearch.com/industry-report/semi-solid-dosage-cdmo-market/market-trends
Semi Solid Dosage CDMO Regional Market Demand @https://www.emergenresearch.com/industry-report/semi-solid-dosage-cdmo-market/regional-market-demand
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Semi Solid Dosage CDMO Market Size is expected to have the highest CAGR from 2022 to 2033 | Emergen Research here
News-ID: 3837010 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for CDMO
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract…
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Inhalation CDMO Market Size During the Forecast Period?
In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024…
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size?
The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of…
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest…
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage
A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications.
The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for…
